MT-1186

Clinical Pharmacology Study of Oral Edaravone in Patients With Amyotrophic Lateral Sclerosis

Clinical Pharmacology Study of Oral Edaravone in Amyotrophic Lateral Sclerosis Patients With Gastrostomy

Clinical Pharmacology Study of Oral Edaravone in Healthy Adult Males (Drug Interaction Study and Preliminary Regimen-Finding Study)

Study of Oral Edaravone in Healthy Adult Males

Bioequivalence Study of Oral Suspension and Intravenous Formulation of Edaravone in Healthy Adult Subjects

Comparative Bioavailability Study of Oral Edaravone Administered Orally and Via a Nasogastric Tube

Clinical Pharmacology Study of Oral Edaravone in Healthy Adult Subjects (Food Effect Study)

Safety Study of Oral Edaravone Administered in Subjects With ALS

Efficacy and Safety Study of Oral Edaravone Administered in Subjects With ALS

Safety Extension Study of Oral Edaravone Administered in Subjects With Amyotrophic Lateral Sclerosis (ALS)

Efficacy and Safety Extension Study of Oral Edaravone Administered in Subjects With ALS

Extension Study Following the Studies MT-1186-A03 or A04 to Evaluate the Safety of Oral Edaravone in Subjects With ALS